| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.19 | 9e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |